Venlafaxine Hydrochloride
Product Images NDC 58118-0097

10 FDA label images from Clinical Solutions Wholesale, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 58118-0097). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Clinical Solutions Wholesale, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

00093738456

00093738456
Venlafaxine Hydrochloride capsules shown in a two-tone color scheme with one half gray and the other half cream. The capsules are imprinted with the numbers "93 7384" on the gray and cream sides. The image includes a millimeter scale for size reference. Labeler is Clinical Solutions Wholesale, LLC.*
FDA Label Image

00093738556

00093738556
Venlafaxine Hydrochloride capsules in pale yellow color with imprint "93 7385" on one side. Capsules are smooth, oblong, and shown from both sides on a gray background with millimeter scale for size reference. Labeler is Clinical Solutions Wholesale, LLC.*
FDA Label Image

00093738656

00093738656
Venlafaxine Hydrochloride capsules are solid, glossy, orange-colored, and imprinted with "93 7386" on one side. The image shows two capsules from different angles against a gray background with a millimeter scale for size reference. The capsules are manufactured or labelled by Clinical Solutions Wholesale, LLC.*
FDA Label Image

Figure 1: Effect Of Interacting Drugs On The Pharmacokinetics Of Venlafaxine And Active Metaboilte O-desmethylvenlafaxine (odv). (Image 01)

Figure 1: Effect Of Interacting Drugs On The Pharmacokinetics Of Venlafaxine And Active Metaboilte O-desmethylvenlafaxine (odv). (Image 01)
A fold change and 90% confidence interval chart showing the pharmacokinetic interactions of various drugs with venlafaxine. The x-axis represents change relative to reference values, and the y-axis lists interacting drugs (ethanol, diazepam, cimetidine, ketoconazole in CYP2D6 EM's and PM's, indinavir, metoprolol, imipramine, lithium) alongside analytes (venlafaxine and ODV) and pharmacokinetic parameters (Cmax, AUC, and NEC). Recommendations for each interaction range from avoiding concomitant use to no dose adjustment needed.*
FDA Label Image

Figure 2: Effect Of Venlafaxine On The Pharmacokinetics Interacting Drugs And Their Active Metabolites. (Image 02)

Figure 2: Effect Of Venlafaxine On The Pharmacokinetics Interacting Drugs And Their Active Metabolites. (Image 02)
A chart showing fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax and AUC) of various interacting drugs with Venlafaxine Hydrochloride. The chart categorizes drugs by name, displaying recommendations such as dose adjustments or clinical significance notes for concurrent use, with a horizontal axis representing change relative to the reference value.*
FDA Label Image

Figure3:pharmacokineticsofvenlafaxineanditsmetaboliteo-desmethylvenlafaxine(odv)inspecialpopulations. (Image 03)

Figure3:pharmacokineticsofvenlafaxineanditsmetaboliteo-desmethylvenlafaxine(odv)inspecialpopulations. (Image 03)
A scatter plot chart showing fold changes and 90% confidence intervals for pharmacokinetic parameters of venlafaxine and its metabolite ODV in special populations such as hepatic impairment, renal impairment, CYP2D6 polymorphism, age over 60 years, and gender. The x-axis represents change relative to the reference value, while the y-axis lists study groups with PK parameters Cmax and AUC. Dose adjustment recommendations are included for each group.*
FDA Label Image

Structural Formula For Venlafaxine Hydrochloride (Image 04)

Structural Formula For Venlafaxine Hydrochloride (Image 04)
Chemical structure of venlafaxine hydrochloride showing its molecular formula with labeled functional groups including methoxy, hydroxyl, and dimethylamino groups attached to a cyclohexane and benzene ring.*
FDA Label Image

Venlafaxine HCl Er 37.5mg Capsule 30 Count Blister Card (Image 05)

Venlafaxine HCl Er 37.5mg Capsule 30 Count Blister Card (Image 05)
Venlafaxine Hydrochloride ER 37.5mg Capsules label from Clinical Solutions Wholesale, LLC. Displays NDC 00093-7384-56, lot number SAMPLE123, and batch SAMPLE456. Manufactured by Teva Pharmaceuticals USA in North Wales, PA. Label includes package quantity of 30 capsules and expiration date October 2018.*
FDA Label Image

Venlafaxine HCl Er 75mg Capsule 30 Count Blister Card (Image 06)

Venlafaxine HCl Er 75mg Capsule 30 Count Blister Card (Image 06)
The label for Venlafaxine HCl ER 75mg Capsules by Clinical Solutions Wholesale, LLC, displays the product name, strength, dosage form, and quantity of 30 capsules. It includes the NDC number 58118-00096-8, manufacturer information for Teva Pharmaceuticals USA Inc, and batch/lot numbers. The label features a QR code and storage instructions for temperature conditions.*
FDA Label Image

Venlafaxine HCl Er 150mg Capsule 30 Count Blister Card (Image 07)

Venlafaxine HCl Er 150mg Capsule 30 Count Blister Card (Image 07)
Packaging label for Venlafaxine HCl ER 150mg capsules by Clinical Solutions Wholesale, LLC. Displays NDC 58118-0097-8, manufacturer information including Teva Pharmaceuticals USA, lot number SAMPLE123, and batch number SAMPLE456. Includes manufacture and expiration dates, storage instructions, and distributor address in Franklin, TN.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.